News from NORD

NORD Submits Letter to Congress on Pre-Existing Conditions


 

In its efforts to protect health care coverage of patients with rare diseases, NORD has submitted a letter to Congress emphasizing the importance of health insurance protection for patients with rare diseases in any legislation drafted to replace the Affordable Care Act.

Recommended Reading

CORD Offers Consensus Framework for Ethical Collaboration
MDedge Hematology and Oncology
NORD Publishes Report on Spontaneous Intracranial Hypotension (SIH)
MDedge Hematology and Oncology
Alport Syndrome Foundation Announces Research Funding
MDedge Hematology and Oncology
Aplastic Anemia & MDS International Foundation Research Portal Is Open
MDedge Hematology and Oncology
APS Type 1 Symposium Is Planned
MDedge Hematology and Oncology
Foundation for Prader-Willi Research Highlights Study of Genetic Therapy for Prader-Willi Syndrome
MDedge Hematology and Oncology
Guidelines tackle long-term screening, management of myeloma
MDedge Hematology and Oncology
GAO to launch investigation of FDA’s Orphan Drug program
MDedge Hematology and Oncology
NORD Awards Grants for Rare Disease Research
MDedge Hematology and Oncology
NORD Publishes Basic Principles for Health Coverage Reform
MDedge Hematology and Oncology